Get started
Fusion Pharmaceuticals Inc.Fusion Pharmaceuticals Inc.Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

FUSN chart

Key stats

Market capitalization
‪1.80 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.47USD
Net income
‪−94.90 M‬USD
Revenue
‪2.07 M‬USD
Shares float
‪56.86 M‬
Beta (1Y)
2.81

About Fusion Pharmaceuticals Inc.

Sector
Health Technology
CEO
John Valliant
Headquarters
Hamilton
Website
fusionpharma.com
Employees (FY)
113
Founded
2014
ISIN
CA36118A1003
FIGI
BBG00V9VQ3R9
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FUSN is 21.26 USD — it has increased by 0.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fusion Pharmaceuticals Inc. stocks are traded under the ticker FUSN.
Fusion Pharmaceuticals Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
FUSN stock is 0.66% volatile and has beta coefficient of 2.81. Check out the list of the most volatile stocks — is Fusion Pharmaceuticals Inc. there?
One year price forecast for Fusion Pharmaceuticals Inc. has a max estimate of 24.00 USD and a min estimate of 18.00 USD.
FUSN earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.40 USD resulting in a 37.51% surprise. The estimated earnings for the next quarter are −0.34 USD per share. See more details about Fusion Pharmaceuticals Inc. earnings.
Fusion Pharmaceuticals Inc. revenue for the last quarter amounts to ‪2.01 M‬ USD despite the estimated figure of ‪86.00 K‬ USD. In the next quarter revenue is expected to reach ‪412.40 K‬ USD.
Yes, you can track Fusion Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
FUSN stock has fallen by 0.42% compared to the previous week, the month change is a 0.62% rise, over the last year Fusion Pharmaceuticals Inc. has showed a 446.53% increase.
FUSN net income for the last quarter is ‪−28.18 M‬ USD, while the quarter before that showed ‪−17.25 M‬ USD of net income which accounts for −63.34% change. Track more Fusion Pharmaceuticals Inc. financial stats to get the full picture.
Today Fusion Pharmaceuticals Inc. has the market capitalization of ‪1.80 B‬, it has increased by 0.52% over the last week.
No, FUSN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, FUSN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fusion Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
FUSN reached its all-time high on Apr 4, 2024 with the price of 21.55 USD, and its all-time low was 1.98 USD and was reached on Nov 7, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 113.00 employees. See our rating of the largest employees — is Fusion Pharmaceuticals Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fusion Pharmaceuticals Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fusion Pharmaceuticals Inc. stock shows the buy signal. See more of Fusion Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Fusion Pharmaceuticals Inc. future price: according to them, FUSN price has a max estimate of 24.00 USD and a min estimate of 18.00 USD. Read a more detailed Fusion Pharmaceuticals Inc. forecast: see what analysts think of Fusion Pharmaceuticals Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fusion Pharmaceuticals Inc. EBITDA is ‪−96.22 M‬ USD, and current EBITDA margin is ‪−4.73 K‬%. See more stats in Fusion Pharmaceuticals Inc. financial statements.